Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma

[1]  Zheng Hu,et al.  Erratum to: Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma , 2015, Molecular cancer.

[2]  Hao Wang,et al.  Reduced CTGF Expression Promotes Cell Growth, Migration, and Invasion in Nasopharyngeal Carcinoma , 2013, PloS one.

[3]  Huiling Yang,et al.  Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma , 2013, Cell Death and Disease.

[4]  G. Nikkhah,et al.  Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas. , 2013, Cancer letters.

[5]  R. Chiarle,et al.  Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer. , 2013, Gastroenterology.

[6]  F. Marincola,et al.  Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma , 2013, Cell Death and Disease.

[7]  S. Keir,et al.  Reversing the Warburg Effect as a Treatment for Glioblastoma* , 2013, The Journal of Biological Chemistry.

[8]  L. Chin,et al.  Passenger Deletions Generate Therapeutic Vulnerabilities in Cancer , 2012, Nature.

[9]  A. Loukas,et al.  Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma. , 2012, Clinical biochemistry.

[10]  Hao Wang,et al.  ZEB2 Mediates Multiple Pathways Regulating Cell Proliferation, Migration, Invasion, and Apoptosis in Glioma , 2012, PloS one.

[11]  H. Klocker,et al.  Estrogen promotes prostate cancer cell migration via paracrine release of ENO1 from stromal cells. , 2012, Molecular endocrinology.

[12]  T. Han,et al.  Cyclin G1–mediated epithelial‐mesenchymal transition via phosphoinositide 3‐kinase/Akt signaling facilitates liver cancer progression , 2012, Hepatology.

[13]  M. Hou,et al.  Overexpression of α-enolase correlates with poor survival in canine mammary carcinoma , 2011, BMC veterinary research.

[14]  Helmut Kettenmann,et al.  The brain tumor microenvironment , 2011, Glia.

[15]  Zhen Liu,et al.  Decreased expression of updated NESG1 in nasopharyngeal carcinoma: Its potential role and preliminarily functional mechanism , 2011, International journal of cancer.

[16]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[17]  J. Köhrle,et al.  Proteomic approach reveals novel targets for retinoic acid-mediated therapy of thyroid carcinoma , 2010, Molecular and Cellular Endocrinology.

[18]  C. Thompson,et al.  Glutamine addiction: a new therapeutic target in cancer. , 2010, Trends in biochemical sciences.

[19]  Stephen Yip,et al.  Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers , 2010, The Lancet Neurology.

[20]  Chien Chou,et al.  Diagnostic detection of human lung cancer-associated antigen using a gold nanoparticle-based electrochemical immunosensor. , 2010, Analytical chemistry.

[21]  T. Wong,et al.  ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction. , 2010, European journal of cancer.

[22]  I. Pollack,et al.  Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas , 2009, International journal of cancer.

[23]  Huiling Yang,et al.  Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma , 2010, BMC Cancer.

[24]  Huiling Yang,et al.  Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma , 2010, Molecular Cancer.

[25]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[26]  Pixu Liu,et al.  Targeting the phosphoinositide 3-kinase pathway in cancer , 2009, Nature Reviews Drug Discovery.

[27]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[28]  L. Cantley,et al.  PI3K pathway alterations in cancer: variations on a theme , 2008, Oncogene.

[29]  Tatyana Chernova,et al.  Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition. , 2007, Molecular biology of the cell.

[30]  Ping He,et al.  Proteomics‐based identification of α‐enolase as a tumor antigen in non‐small lung cancer , 2007 .

[31]  G. Das,et al.  Differential expression and role of p21cip/waf1 and p27kip1 in TNF-α-induced inhibition of proliferation in human glioma cells , 2007, Molecular Cancer.

[32]  P. Kleihues,et al.  Genetic pathways to primary and secondary glioblastoma. , 2007, The American journal of pathology.

[33]  T. Nishida,et al.  Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer. , 2006, Cancer science.

[34]  Stephanie Daignault,et al.  Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer. , 2006, Cancer research.

[35]  Michael Weller,et al.  Changing paradigms--an update on the multidisciplinary management of malignant glioma. , 2006, The oncologist.

[36]  G. Gobbel,et al.  Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis , 2005, Laboratory Investigation.

[37]  Chi V Dang,et al.  Multifaceted roles of glycolytic enzymes. , 2005, Trends in biochemical sciences.

[38]  K. Greulich,et al.  Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. , 2004, Genomics.

[39]  W. Hong,et al.  Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  S. Bonhoeffer,et al.  Cooperation and Competition in the Evolution of ATP-Producing Pathways , 2001, Science.

[41]  S. Bombardieri,et al.  Surface expression of a glycolytic enzyme, α‐enolase, recognized by autoantibodies in connective tissue disorders , 2000 .

[42]  A. Keller,et al.  Differential modulation of α, β and γ enolase isoforms in regenerating mouse skeletal muscle , 2000 .

[43]  A. Keller,et al.  Differential modulation of alpha, beta and gamma enolase isoforms in regenerating mouse skeletal muscle. , 2000, European journal of biochemistry.

[44]  S. Bombardieri,et al.  Surface expression of a glycolytic enzyme, alpha-enolase, recognized by autoantibodies in connective tissue disorders. , 2000, European journal of immunology.

[45]  B. Dutrillaux,et al.  Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure. , 1997, Anticancer research.

[46]  G. Semenza,et al.  Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1* , 1996, The Journal of Biological Chemistry.

[47]  F. Apiou,et al.  High glycolysis in gliomas despite low hexokinase transcription and activity correlated to chromosome 10 loss. , 1996, British Journal of Cancer.

[48]  J. Carreras,et al.  Enolase Activity and Isoenzyme Distribution in Human Brain Regions and Tumors , 1996, Journal of neurochemistry.

[49]  A. Giallongo,et al.  Complete structure of the human gene encoding neuron-specific enolase. , 1991, Genomics.

[50]  G. Barbieri,et al.  Structure of the human gene for α‐enolase , 1990 .

[51]  G. Barbieri,et al.  Structure of the human gene for alpha-enolase. , 1990, European journal of biochemistry.

[52]  J. Royds,et al.  Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological change , 1981, Journal of neurology, neurosurgery, and psychiatry.